Immunome (IMNM) Share-based Compensation (2019 - 2026)
Immunome (IMNM) reported Share-based Compensation of $8.8 million for Q2 2026, up 64.6% from $5.35 million a year earlier and up 10.6% from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Share-based Compensation (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immunome's Share-based Compensation came in at $31.39 million, up 46.6% year-over-year; for FY2025, it came in at $25.69 million, up 63.1% from FY2024.
- Share-based Compensation has increased for five consecutive years, with a five-year compound annual growth rate of 110.5% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $15.75 million in FY2024 (+153.1%), $6.22 million in FY2023 (+16.7%), $5.33 million in FY2022 (+54.6%) and $3.45 million in FY2021 (+455.2%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation in data going back to Q4 2019.
- Year over year, Share-based Compensation has now increased in each of the last 11 quarters, with growth averaging 107.2% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 887.2%); the low point was Q2 2023 (a decline of 22.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.95 million (Q1 2026), $7.89 million (Q4 2025) and $6.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Immunome | 2.46 Bn | 429.67 Mn | - | 8.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.80 Mn |
| Mar 31, 2026 | 7.95 Mn |
| Dec 31, 2025 | 7.89 Mn |
| Sep 30, 2025 | 6.75 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.70 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 2.88 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 1.22 Mn |
| Dec 31, 2022 | 1.36 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 1.33 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 1.22 Mn |
| Sep 30, 2021 | 1.16 Mn |
API Access
Immunome Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();